Buprenorphine: a treatment and cause of opioid-induced respiratory depression
- PMID: 34996591
- DOI: 10.1016/j.bja.2021.12.001
Buprenorphine: a treatment and cause of opioid-induced respiratory depression
Abstract
Buprenorphine is a partial agonist at the mu opioid receptor. Due to its relatively low maximum effect on respiratory depression it is considered by some to be a safe opioid. But it can produce serious respiratory depression, particularly when combined with sedatives such as benzodiazepines.
Keywords: benzodiazepine; breathing; buprenorphine; opioid-induced respiratory depression; partial agonism.
Copyright © 2021 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.
Comment on
-
Mechanisms of respiratory depression induced by the combination of buprenorphine and diazepam in rats.Br J Anaesth. 2022 Mar;128(3):584-595. doi: 10.1016/j.bja.2021.10.029. Epub 2021 Dec 4. Br J Anaesth. 2022. PMID: 34872716
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials